Structural heart (SH) programs do not stall because of a lack of demand – they plateau because of capacity constraints. As the population over age 65 surges and transcatheter therapies expand rapidly, even high‑performing programs are facing full procedure days, saturated clinics, imaging bottlenecks and growing referral backlogs. These resource strains carry real clinical consequences, especially for conditions like severe aortic stenosis where delays worsen outcomes. Designed for cardiovascular leaders, a new CV business white paper outlines the early warning signs of a capacity-limited program and offers a strategic roadmap to move beyond operational tweaks and make the infrastructure investments needed to sustain growth in the next era of SH care.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
